Julie Crawshay's Evidence-Based Approach to GBM Information

One question Julie Crawshay is often asked is how The Neuro Farmacist decides what information to share. Because a Glioblastoma diagnosis is frightening, misinformation spreads quickly — so a careful, evidence-based approach matters.
Starting with peer-reviewed research

Julie Crawshay grounds The Neuro Farmacist in peer-reviewed literature, established clinical guidelines and reputable organisations rather than anecdote. Where the evidence is uncertain or evolving — as it often is with GBM — she says so plainly instead of overstating what is known.
Translating, not simplifying away the truth
The goal Julie Crawshay sets for every article is to make complex brain cancer science understandable without stripping out the nuance families need to make decisions with their medical team. Clear does not mean dumbed-down.
Always pointing back to the care team
The Neuro Farmacist is educational, and Julie Crawshay is careful to frame it that way: nothing here replaces advice from a patient's neuro-oncologist. Her aim is to help families ask better questions and feel less overwhelmed, not to diagnose or treat.
— Julie Crawshay, The Neuro Farmacist